Razadyne vs. Lexapro: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Razadyne and Lexapro. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 171,952 people who take Razadyne and Lexapro, and is updated regularly.
What is Razadyne?
Razadyne has active ingredients of galantamine hydrobromide. It is often used in insomnia. eHealthMe is studying from 691 Razadyne users. Check the latest studies of Razadyne.
What is Lexapro?
Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
171,952 people who take Razadyne and Lexapro are studied.
Drugs being compared in this study:
- Razadyne (galantamine hydrobromide)
- Lexapro (escitalopram oxalate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Razadyne:
- not at all: 6.82 %
- somewhat: 30.68 %
- moderate: 26.14 %
- high: 31.82 %
- very high: 4.55 %
Lexapro:
- not at all: 3.9699999999999998 %
- somewhat: 19.07 %
- moderate: 36.97 %
- high: 29.87 %
- very high: 10.12 %
Want to compare Razadyne with Lexapro?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Razadyne:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lexapro:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on galantamine hydrobromide and escitalopram oxalate (the active ingredients of Razadyne and Lexapro, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prednisone and Gallbladder Disease for Women aged 30-39 - now
- Drug interactions of Megace and Lovenox - now
- Bladder Cancer and drugs of ingredients of imatinib mesylate - a second ago
- Soft Tissue Injury and drugs of ingredients of alprazolam - 6 seconds ago
- Coronary Heart Disease and drugs of ingredients of pamidronate disodium - 7 seconds ago
- Librium and Depression Aggravated for Women aged 40-49 - 9 seconds ago
- Intestinal Obstruction and drugs of ingredients of mexiletine hydrochloride - 10 seconds ago
- Could Methylprednisolone cause Injection Site Rash? - 12 seconds ago
- Drug interactions of Promethegan and Temaz - 12 seconds ago
- Bone Deformity and drugs of ingredients of warfarin sodium - 14 seconds ago